Competitive intelligence

Side-by-side comparison

Up to six companies on the same rows. Empty cells say what is missing rather than hiding it.

4 of 6 columns

Comparison

Side-by-side comparison of Entera Bio Ltd., Pluri Inc., Hepion Pharmaceuticals, Inc., Gossamer Bio, Inc.
AttributeEntera Bio Ltd.9.2removePluri Inc.9.0removeHepion Pharmaceuticals, Inc.8.9removeGossamer Bio, Inc.9.7remove
Signal scores
Radar composite
9.2
9.0
8.9
9.7
IPO signal score
18.4
17.9
17.8
19.3
Tokenization signal score
0.0
0.0
0.0
0.0
On-chain readiness
0.0
0.0
0.0
0.0
MomentumACCELERATING+8.7ACCELERATING+13.2STABLE+5.5ACCELERATING+14.2
Company
Stageprivateprivateprivateprivate
SectorTechnologyTechnologyTechnologyTechnology
HeadquartersJerusalemHAIFARED BANK, United StatesSan Diego, United States
Foundednot on recordnot on recordnot on recordnot on record
Employeesnot on recordnot on recordnot on recordnot on record
Capital
Latest valuationnot on recordnot on recordnot on recordnot on record
Total funding$275M$4M$3M$25M
Latest roundPrivate Placement $275MPrivate Placement $4MPrivate Placement $3MPrivate Placement $25M
Investors on record0000
Evidence
Institutional relationships0000
Active signals16211717
Confidence56%57%59%58%

IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.